MedTech Spectrum

Article Name Clinical & Diagnostic

GE Healthcare and Novo Nordisk Team Up for Non-Invasive Diabetes & Obesity Treatment

GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity.

20th October, 2023

Thermo Fisher Partners with Boehringer for NSCLC Companion Diagnostics

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States

20th October, 2023

Heart Failure May No Longer Be a Life Sentence for Cancer Survivors

Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer.1 The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer

20th October, 2023

FloBio's Bleeding Risk Diagnostic Test Earns FDA's Breakthrough Device Designation

Rapid Detection of Modern Blood Thinners Could Reduce Preventable Complications in US Hospitals

19th October, 2023

BGI Genomics Combats Hepatitis in Ethiopia

Healthcare localization and standardization support the Belt and Road Initiative

19th October, 2023

Voom Medical Devices Introduces Next Generation, Functionally Distinctive Patented Screw

Voom™ Medical Devices launches the distinctive patented Revcon™ Anchor v2.0 screw, the only neutral non-compressive dual-zone pitched single screw solution for minimally invasive bunion surgery, exclusively used with the Bunionplasty® procedure.

19th October, 2023

GE Healthcare Gets FDA Clearance for Allia IGS Pulse: Next-Gen Cardiac Imaging System

GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.

17th October, 2023

IIT-D ( India ) designs scalable wearable pressure sensor to analyse gait patterns and postural deformities

Sensor can potentially provide an easy, low-cost alternative to expensive footwear modifications

17th October, 2023

Boston Scientific Gets FDA Nod for Spinal Cord Stimulation in Diabetic Neuropathy

Nearly 50% of American adults living with diabetes will be affected by diabetic neuropathy complications in their lifetime

14th October, 2023

Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and national availability of its ATN Profile, a blood-based test that combines three, well-researched blood biomarkers to identify and assess biological changes associated with Alzheimer's disease – amyloid plaques, tau tangles and neurodegeneration (ATN) – which can help accelerate the path to diagnosis and intervention.i The test is available through physicians for use with patients who are being evaluated for possible Alzheimer's disease or other causes of cognitive impairment based on clinical observation and cognitive screenings.

13th October, 2023

Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention

Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics

13th October, 2023

Sigrid Therapeutics Announces First Patient Treated with SiPore21® Medical Device for Sustained Diabetes and Obesity Control

Sigrid Therapeutics announces the commencement of the SHINE clinical trial for SiPore21® – an innovative medical device designed for sustained diabetes and weight control. Based on Mesoporous Silica particles (MSPs), SiPore21® represents a groundbreaking approach to managing these pressing health concerns. Administered orally in gel form, MSPs act as "molecular sieves," physically preventing digestive enzymes from interacting with food, thereby reducing the breakdown of carbohydrates and fats.

11th October, 2023

DELFI Diagnostics Introduces FirstLook Lung: A Breakthrough in Blood-Based Lung Cancer Screening

FirstLook Lung uses a breakthrough technology of whole-genome machine learning to analyze fragments of cell-free DNA that are markers of cancer in the blood

11th October, 2023

BLK-Max Hospital collaborates with Intuitive to launch robot-assisted surgery fellowship training programme

Programme aims to address the growing demand for skilled robotic-assisted surgeons in India

11th October, 2023

Korean startup Noul enters cancer diagnostic biz with launch of cervical cell analysis product

To overcome the limitations of Human Papillomavirus (HPV) testing by identifying the detailed stages of cervical pre-cancer/cancer with cervical cytology

11th October, 2023

Make government’s guidelines universally enforceable to control hospital acquired infections: Experts

A nearly 30% increase in the mortality rate in hospitals can be attributed to poor infection management

09th October, 2023

“There is a need for more innovations in the way healthcare is delivered at the point-of-care level”

The reimagination of health systems in India is turning towards a central role being played by point-of-care tests that are accessible and affordable, to enable early detection and timely treatment of a number of diseases impacting India. This not only includes the current monsoon related spike in malaria cases that has surged by 40 per cent over last year's count, but also makes us reflect upon the fact that for the majority of tuberculosis (TB) testing, age-old microscopy technique still holds a major share. Addressing this demand for high-quality, point-of-care molecular diagnostic systems that is higher than ever today, Goa-based in-vitro diagnostic company Molbio Diagnostics is accelerating work on newer technologies. In conversation with MedTech Spectrum & BioSpectrum, Sriram Natarajan, Director and Chief Executive Officer, Molbio Diagnostics spoke in detail about the country’s healthcare challenges and the company’s contribution in attending to those challenges with novel ideas.

05th October, 2023

Transforming Healthcare With Generative AI

Generative AI is selling itself to emerge as the new frontier in the horizon for the booming healthcare industry. Highlighting some of the significant developments in this technology space, this article has a few Indian leaders voicing their opinions on exploring Generative AI to progress their businesses and services.

04th October, 2023